Additionally, immunohistochemistry (IHC) confirmed a dramatic loss of SMARCA4 and POU2F3 protein expression in the AU-24118-treated SCLC-P samples, as well as decreased DCLK1 expression - a tuft cell marker (Fig. 3D, Fig. S5C). This evidence concerns the gene POU2F3 and small cell lung carcinoma.